Clinical Trial Update: Study in Patients With Mild to Moderate Psoriasis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial in mild to moderate psoriasis completed; study sponsored by Alimentary Health Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Alimentary Health Ltd psoriasis product

Snippet

Sponsor: Alimentary Health Ltd | Conditions: Psoriasis | Phase 1, Phase 2 | Status: COMPLETED